HippoFi

HippoFi, Inc. is a healthcare innovator, delivering proprietary technologies in the multi-billion-dollar Spine, Orthopedic, and Cancer markets. The company is headquartered in Irvine, California. The company went IPO on 2006-08-01. The firm is engaged in delivering proprietary technologies in the multi-billion-dollar Spine, Orthopedic and Cancer markets. The company is focused on improving patient care and outcomes by utilizing biotech and AI technologies to address degenerative and diseased conditions affecting the quality of life. Its business is designed to drive the Company’s value by commercializing and monetizing advanced solutions, acquiring assets, and licensing technologies, establishing strategic partnerships and industry alliances, and leveraging worldwide sales channels. Its operations comprise two segments: Regenerative Therapeutics and Intelligent Automation. Regenerative Therapeutics division is actively developing and deploying scalable biological solutions into the biotechnology market through its wholly owned subsidiary, PUR Biologics, LLC (PUR). The company is also focused on implementing solutions in the Biotech, Fintech, and AI markets.